Brief: Piramal Pharma (Mumbai) Says Commercial Arrangement With Bayer Pharmaceuticals To Expire On December 31, 2026
01/10/2026 16:10
BRIEF-Piramal Pharma (Mumbai) Says Commercial Arrangement With Bayer Pharmaceuticals To Expire On December 31, 2026 Oct 1 (Reuters) - Piramal Pharma Ltd (Mumbai) PIRM.NS:
PIRAMAL PHARMA (MUMBAI) - COMMERCIAL ARRANGEMENT WITH BAYER PHARMACEUTICALS TO EXPIRE ON DECEMBER 31, 2026
PIRAMAL PHARMA (MUMBAI) - DISTRIBUTION ARRANGEMENT WITH BAYER PHARMACEUTICALS WILL NOT BE RENEWED
PIRAMAL PHARMA (MUMBAI) - REVENUE FROM ARRANGEMENT ACCOUNTS FOR LESS THAN 5% OF CONSOLIDATED REVENUE
Source text: ID:nBSE4vmGKB
Further company coverage: PIRM.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Piramal Pharma (Mumbai)
See all newsBrief: Piramal Pharma (Mumbai) Says Commercial Arrangement With Bayer Pharmaceuticals To Expire On December 31, 2026
Brief: Piramal Pharma (Mumbai) Says Tax Authority Confirms Demand Of 40.6 Million Rupees And Imposes Equivalent Penalty
India's Piramal Pharma falls after US FDA observations at UK facility
Brief: Piramal Pharma Says US FDA Issues Form-483 With 7 Observations To Morpeth UK Facility
Brief: Piramal Pharma Approves Exercise Of Call Option For Acquisition Of Additional 41% Equity In Yapan Bio